两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-22-008762 Act: 34 Size: 4 MB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-058784 Act: 34 Size: 263 KB 网页链接
$Onconova医疗(ONTX)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-22-053710 Act: 34 Size: 685 KB 网页链接
$Onconova医疗(ONTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-22-004015 Act: 34 Size: 7 MB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-035003 Act: 34 Size: 260 KB 网页链接
$Onconova医疗(ONTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-022525 Act: 34 Size: 60 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-22-000964 Size: 7 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-22-000963 Size: 7 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-22-000961 Size: 7 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-22-000962 Size: 7 KB 网页链接